Insider trading

Period: 120 months Stock: SERA + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

197 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

197 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

197 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

197 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
197 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
197 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

197 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
8 May 2024
Kearney Paul Chief Data Officer
Sold at will
$40.33K 4,205 at 9.59
2.6%
Not planned
28 Mar 2024
Boniface John J. Chief Scientific Officer
Sold on a plan
$221.24K 24,474 at 9.04
14.9%
Planned (10b5-1)
27 Mar 2024
Boniface John J. Chief Scientific Officer
Sold on a plan 2×
$506.61K 52,662 at 9.62
27.4%
Planned (10b5-1)
26 Mar 2024
Lindgardt Zhenya Chief Executive Officer
Sold at will
$364.48K 38,899 at 9.37
4.1%
Not planned
26 Mar 2024
Boniface John J. Chief Scientific Officer
Sold at will
$204.73K 21,438 at 9.55
13.0%
Not planned
26 Mar 2024
Aerts Austin Chief Financial Officer
Sold at will
$75.82K 8,092 at 9.37
2.4%
Not planned
25 Mar 2024
Boniface John J. Chief Scientific Officer
Sold at will
$201.68K 22,163 at 9.10
11.8%
Not planned
6 Mar 2024
Harrison Robert Gardner Chief Information Officer
Sold at will
$19.28K 2,138 at 9.02
1.4%
Not planned
6 Mar 2024
Jackson Benjamin General Counsel
Sold at will
$16.74K 1,856 at 9.02
1.2%
Not planned
6 Mar 2024
Boniface John J. Chief Scientific Officer
Sold at will
$15.01K 1,664 at 9.02
0.9%
Not planned
6 Mar 2024
Kearney Paul Chief Data Officer
Sold at will
$9.27K 1,028 at 9.02
0.6%
Not planned
6 Mar 2024
Aerts Austin Chief Financial Officer
Sold at will
$4.00K 444 at 9.02
0.1%
Not planned
6 Feb 2024
Lindgardt Zhenya Chief Executive Officer
Sold at will
$224.82K 27,997 at 8.03
2.9%
Not planned
6 Feb 2024
Aerts Austin Chief Financial Officer
Sold at will
$78.58K 9,786 at 8.03
2.9%
Not planned
6 Feb 2024
Jackson Benjamin General Counsel
Sold at will
$45.49K 5,665 at 8.03
3.6%
Not planned
6 Feb 2024
Boniface John J. Chief Scientific Officer
Sold at will
$45.49K 5,665 at 8.03
2.9%
Not planned
6 Feb 2024
Harrison Robert Gardner Chief Information Officer
Sold at will
$45.49K 5,665 at 8.03
3.7%
Not planned
6 Feb 2024
Kearney Paul Chief Data Officer
Sold at will
$40.02K 4,984 at 8.03
3.0%
Not planned
7 Dec 2023
Jackson Benjamin General Counsel
Sold at will
$52.20K 10,000 at 5.22
6.0%
Not planned
7 Dec 2023
Boniface John J. Chief Scientific Officer
Sold at will
$24.00K 5,000 at 4.80
2.5%
Not planned
5 Jun 2023
Harrison Robert Gardner Chief Information Officer
Sold at will
$16.15K 5,000 at 3.23
14.9%
Not planned
27 Jul 2022
Boniface John J. Chief Scientific Officer
Sold, plan not stated
$2.22K 1,000 at 2.22
2.1%
26 Jul 2022
Boniface John J. Chief Scientific Officer
Sold, plan not stated
$5.86K 2,725 at 2.15
5.5%
19 Jul 2022
Boniface John J. Chief Scientific Officer
Sold, plan not stated
$5.07K 2,725 at 1.86
5.2%
12 Jul 2022
Boniface John J. Chief Scientific Officer
Sold, plan not stated
$5.01K 2,725 at 1.84
5.0%
5 Jul 2022
Boniface John J. Chief Scientific Officer
Sold, plan not stated
$4.44K 2,725 at 1.63
4.7%
29 Jun 2022
Boniface John J. Chief Scientific Officer
Sold, plan not stated
$1.72K 1,000 at 1.72
1.7%
28 Jun 2022
Boniface John J. Chief Scientific Officer
Sold, plan not stated
$5.15K 2,725 at 1.89
4.5%
21 Jun 2022
Boniface John J. Chief Scientific Officer
Sold, plan not stated
$3.57K 2,725 at 1.31
4.3%
14 Jun 2022
Jackson Benjamin General Counsel
Bought
$9.60K 8,000 at 1.20
opened
First buy on file
14 Jun 2022
Boniface John J. Chief Scientific Officer
Sold, plan not stated
$3.30K 2,725 at 1.21
4.2%
7 Jun 2022
Boniface John J. Chief Scientific Officer
Sold, plan not stated
$3.54K 2,725 at 1.30
4.0%
1 Jun 2022
Boniface John J. Chief Scientific Officer
Sold, plan not stated
$1.36K 1,000 at 1.36
1.4%
31 May 2022
Boniface John J. Chief Scientific Officer
Sold, plan not stated
$3.95K 2,725 at 1.45
3.8%
24 May 2022
Boniface John J. Chief Scientific Officer
Sold, plan not stated
$4.20K 2,725 at 1.54
3.7%
17 May 2022
Boniface John J. Chief Scientific Officer
Sold, plan not stated
$4.22K 2,725 at 1.55
3.6%
10 May 2022
Boniface John J. Chief Scientific Officer
Sold, plan not stated
$5.37K 2,725 at 1.97
3.4%
4 May 2022
Boniface John J. Chief Scientific Officer
Sold, plan not stated
$2.17K 1,000 at 2.17
1.2%
3 May 2022
Boniface John J. Chief Scientific Officer
Sold, plan not stated
$5.91K 2,725 at 2.17
3.3%
26 Apr 2022
Boniface John J. Chief Scientific Officer
Sold, plan not stated
$5.91K 2,725 at 2.17
3.2%
19 Apr 2022
Boniface John J. Chief Scientific Officer
Sold, plan not stated
$5.67K 2,725 at 2.08
3.1%
12 Apr 2022
Boniface John J. Chief Scientific Officer
Sold, plan not stated
$7.25K 2,725 at 2.66
3.0%
6 Apr 2022
Boniface John J. Chief Scientific Officer
Sold, plan not stated
$3.02K 1,000 at 3.02
1.1%
5 Apr 2022
Boniface John J. Chief Scientific Officer
Sold, plan not stated
$9.13K 2,725 at 3.35
2.9%
29 Mar 2022
Boniface John J. Chief Scientific Officer
Sold, plan not stated
$10.16K 2,725 at 3.73
2.9%
22 Mar 2022
Boniface John J. Chief Scientific Officer
Sold, plan not stated
$10.03K 2,725 at 3.68
2.8%
14 Mar 2022
Boniface John J. Chief Scientific Officer
Sold, plan not stated
$10.74K 2,725 at 3.94
2.7%
Showing 151–197 of 197. ← Newer Page 4 of 4